Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Stage_2019_Basic.Clin.Pharmacol.Toxicol_125_54

Reference

Title: The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios
Stage C, Dalhoff K, Rasmussen HB, Schow Guski L, Thomsen R, Bjerre D, Ferrero-Miliani L, Busk Madsen M, Jurgens G
Ref: Basic Clin Pharmacol Toxicol, 125:54, 2019 : PubMed

        



Related information

Gene_Locus| human-CES1
Mutation | G143E_human-CES1,



Citations formats

Stage C, Dalhoff K, Rasmussen HB, Schow Guski L, Thomsen R, Bjerre D, Ferrero-Miliani L, Busk Madsen M, Jurgens G (2019)
The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios
Basic Clin Pharmacol Toxicol 125: 54-61

Stage C, Dalhoff K, Rasmussen HB, Schow Guski L, Thomsen R, Bjerre D, Ferrero-Miliani L, Busk Madsen M, Jurgens G (2019)
Basic Clin Pharmacol Toxicol 125: 54-61



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer